Journal of Capital Medical University ›› 2020, Vol. 41 ›› Issue (2): 298-301.doi: 10.3969/j.issn.1006-7795.2020.02.027

• Expert Forum • Previous Articles     Next Articles

Value of multidisciplinary cooperation model in the treatment of COVID-19

Ke Jing1, Cao Bin1, Jiang Zhifeng2, Ding Lin3, Liu Zuojun4, Zhang Xiwei5, Li Xiaohui3, Ji Zhili6   

  1. 1. Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China;
    2. Center for Emergency and Severe Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China;
    3. Center for Respiratory Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China;
    4. Center for Digestive Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China;
    5. Department of Nursing, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China;
    6. Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China
  • Received:2020-02-28 Published:2020-04-16

Abstract: More than 70000 people have been infected by the novel coronavirus from Wuhan. It is a great challenge for prevention and treatment of the novel coronavirus pneumonia (COVID-19), due to limited understanding of the COVID-19 and its natural history. Limited data suggested that COVID-19 may cause damage in multiple systems and organs. Moreover, people accompanied with chronic diseases may be more susceptible. This study aimed to explore the clinical value of multidisciplinary cooperation model in the treatment of COVID-19.

Key words: coronavirus, COVID-19, multidisciplinary cooperation model

CLC Number: